Electromed, Inc. (NYSE:ELMD - Get Free Report) Director Andrew Summers sold 12,731 shares of the business's stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total value of $381,675.38. Following the transaction, the director now owns 165,755 shares of the company's stock, valued at approximately $4,969,334.90. The trade was a 7.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Andrew Summers also recently made the following trade(s):
- On Monday, December 2nd, Andrew Summers sold 17,463 shares of Electromed stock. The stock was sold at an average price of $30.09, for a total value of $525,461.67.
Electromed Price Performance
Shares of NYSE ELMD opened at $29.82 on Thursday. The stock has a market capitalization of $252.28 million, a P/E ratio of 41.82 and a beta of 0.29. Electromed, Inc. has a 1-year low of $9.81 and a 1-year high of $31.31. The business has a fifty day moving average price of $24.92 and a 200 day moving average price of $18.95.
Electromed (NYSE:ELMD - Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.13. The firm had revenue of $14.67 million during the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.
Institutional Trading of Electromed
⭕ [URGENT] Buy Alert just triggered
From Behind the Markets | Ad
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Electromed by 1.6% during the first quarter. Vanguard Group Inc. now owns 367,114 shares of the company's stock worth $5,929,000 after purchasing an additional 5,886 shares in the last quarter. Morgan Dempsey Capital Management LLC purchased a new position in Electromed during the second quarter worth approximately $108,000. Renaissance Technologies LLC boosted its position in Electromed by 4.8% during the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company's stock worth $1,548,000 after purchasing an additional 4,736 shares in the last quarter. Pekin Hardy Strauss Inc. purchased a new position in Electromed during the second quarter worth approximately $522,000. Finally, Gabelli Funds LLC boosted its position in Electromed by 7.8% during the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company's stock worth $581,000 after purchasing an additional 2,808 shares in the last quarter. 40.82% of the stock is owned by institutional investors and hedge funds.
About Electromed
(
Get Free Report)
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
